Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

被引：0
|
作者：
Babic, I [1 ,2 ,3 ]
Gorak, A. [1 ,2 ]
Hughes, J. [2 ]
Engel, M. [2 ]
Sellers, D. [1 ,2 ]
Else, P. [2 ]
Lufe, L. [1 ,2 ]
Obeid, A. L. [1 ,2 ]
Osborne, A. L. [1 ,2 ]
Le Mesurier, P. [1 ,2 ]
Pai, N. [2 ,3 ]
Huang, X. F. [1 ,2 ]
Weston-Green, K. [1 ,2 ]
机构：
[1] Univ Wollongong, Ctr Translat Neurosci, Wollongong, NSW 2522, Australia
[2] Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia
[3] Illawarra Shoalhaven Local Hlth Dist, Wollongong, NSW 2500, Australia
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PM426
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [1] Efpeglenatide Glucagon-like peptide 1 (GLP-1) receptor agonist Treatment for type 2 diabetes
    Reid, J.
    Rana, K.
    Segel, S. A.
    Sheikh-Ali, M.
    Choksi, R. R.
    Goldfaden, R. F.
    DRUGS OF THE FUTURE, 2019, 44 (06) : 435 - 441
  • [2] ALBIGLUTIDE Glucagon-Like Peptide GLP-1 Receptor Agonist Treatment of Type 2 Diabetes
    Rosenstock, Julio
    Stewart, Murray W.
    DRUGS OF THE FUTURE, 2010, 35 (09) : 701 - 712
  • [3] Glucagon-like peptide 1 (GLP-1)
    Mueller, T. D.
    Finan, B.
    Bloom, S. R.
    D'Alessio, D.
    Drucker, D. J.
    Flatt, P. R.
    Fritsche, A.
    Gribble, F.
    Grill, H. J.
    Habener, J. F.
    Holst, J. J.
    Langhans, W.
    Meier, J. J.
    Nauck, M. A.
    Perez-Tilve, D.
    Pocai, A.
    Reimann, F.
    Sandoval, D. A.
    Schwartz, T. W.
    Seeley, R. J.
    Stemmer, K.
    Tang-Christensen, M.
    Woods, S. C.
    DiMarchi, R. D.
    Tschoep, M. H.
    MOLECULAR METABOLISM, 2019, 30 : 72 - 130
  • [4] Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes
    Nauck, MA
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 852 - 858
  • [5] Drug-induced Liver Injury Associated with the Glucagon-like Peptide 1 (GLP-1) Agonist Liraglutide
    Kern, Emily
    VanWagner, Lisa
    Rinella, Mary
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S335 - S336
  • [6] Glucagon-like peptide 1 (GLP-1) analogues and weight loss
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (07) : 663 - 663
  • [7] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [8] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19
  • [9] Glucagon-Like Peptide 1 Receptor Agonist (GLP-1 RA) Delays Cyst Growth in ADPKD
    Wu Jiao
    Cheng Shasha
    Zhang Yingying
    Li Xiaoyan
    Zhou Xia
    Li Xiaogang
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [10] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
12345